SCN5A and Alzheimer disease: Likewise, SCN5A had highest upregulation in AD-MSCs (7.8 ± 0.36 change folds), followed by that in BM-MSCs (5.2 ± 0.21 change folds) and DP-MSCs (3.8 ± 0.19 change folds), with no significant difference.